Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 25/02/19 → 31/12/19 |
Keywords
- Neuroscience
- Ischaemic stroke
- Clinical trial
Clinical Trial Phase
- Phase II
A Randomized, Double-blind, Placebo-controlled Phase II Multi-Centre Evaluation to Assess the Safety and Tolerability of DM199 Administered Intravenously and Subcutaneously in Subjects with Acute Ischemic Stroke (ReMEDy Trial).
- Cloud, Geoffrey (Primary Chief Investigator (PCI))
Project: Research